BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
G-protein-coupled receptor binding
,
Inflammatory disorder
,
Retina
,
Nosology
,
IGF1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
UBE2R2
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Testes
Nipple cross-section
Heart ventricle
Esophagus
Oral mucosa
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Functional conservation and divergence of the helix-turn-helix motif of E2 ubiquitin-conjugating enz…
LncRNA UBE2R2-AS1, as prognostic marker, promotes cell proliferation and EMT in prostate cancer.
Robust cullin-RING ligase function is established by a multiplicity of poly-ubiquitylation pathways.
UBE2R2-AS1 Inhibits Xenograft Growth in Nude Mice and Correlates with a Positive Prognosis in Glioma…
Linkage-specific ubiquitin chain formation depends on a lysine hydrocarbon ruler.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Effect of Propofol and Desflurane on Nucleic Acid of Liver Circulating Tumor
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ